Bio-equivalence
Bio-equivalence is defined as the observation and finding similarities of one or more drugs. Formulations involve the same active substance or element are called bio-equivalence. If their rate of absorption and formulations are identical, they are pronounced to be bioequivalence drugs. The United States food and Drug Administration (FDA) has explained bio-equivalence as "the absence of a significant difference in the rate and range to which the active ingredient or active subdivision in pharmaceutical equivalents or pharmaceutical substitute becomes available at the site of drug action when administered at the same molar dose below similar conditions in an appropriately designed study.
- Rate Of immersion
- Expression of Medicines
Related Conference of Bio-equivalence
6th International Conference on Clinical Pharmacology and Toxicology
Bio-equivalence Conference Speakers
Recommended Sessions
- Behavior toxicology
- Bio-availability
- Bio-equivalence
- Biochemical Pharmacology
- Biologic drugs
- Clinical and medical pharmacology
- Drug discovery and Drug development
- Drug Safety
- Environmental Toxicology
- Genotoxicity
- Microbial Toxicology
- Molecular Pharmacology
- Nanomedicine and Nanotechnology
- Pharmaceutical biotechnology
- Pharmacodynamics
- Pharmacogenomics
- Pharmacokinetics
- Pharmacology and Toxicology
- Pharmacovigilance
- Route of administration
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinicalpharmacology2025 (Canada)
- Cardiovascular Pharmacology - clinicalpharmacology2025 (Canada)
- Clinical Toxicology of Drugs of Abuse - clinicalpharmacology2025 (Canada)
- Clinical Trials and Regulatory Affairs - clinicalpharmacology2025 (Canada)
- Drug Interactions and Polypharmacy - clinicalpharmacology2025 (Canada)
- Emerging Trends in Clinical Pharmacology - clinicalpharmacology2025 (Canada)
- Environmental and Occupational Toxicology - clinicalpharmacology2025 (Canada)
- Future Directions in Clinical Pharmacology and Toxicology - clinicalpharmacology2025 (Canada)
- Innovations in Drug Development and Therapeutics - clinicalpharmacology2025 (Canada)
- Natural Products and Toxicology - clinicalpharmacology2025 (Canada)
- Neuropharmacology and Toxicology - clinicalpharmacology2025 (Canada)
- Pediatric and Geriatric Pharmacology - clinicalpharmacology2025 (Canada)
- Pharmacogenomics and Personalized Medicine - clinicalpharmacology2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - clinicalpharmacology2025 (Canada)
- Toxicology and Risk Assessment - clinicalpharmacology2025 (Canada)